Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

Trial Identifier: D3465C00002
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT05339100
Start Date: March 2022
Primary Completion Date: April 2023
Study Completion Date: April 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Berlin, DE, 14050
GB Harrow, GB, HA1 3UJ
US, MD Brooklyn, MD, US, 21225